Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,179 | -40,146 | -18,728 | -78,254 | -56,759 |
| Depreciation Amortization | 580 | 318 | 106 | -400 | -437 |
| Accounts payable and accrued liabilities | -539 | 1,318 | 262 | 2,583 | 1,834 |
| Other Working Capital | -6,036 | -4,537 | -4,591 | 7,104 | 3,271 |
| Other Operating Activity | 5,531 | 1,940 | 1,257 | 3,275 | 2,693 |
| Operating Cash Flow | $-58,643 | $-41,107 | $-21,694 | $-65,692 | $-49,398 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -32,944 | -39,294 | 16,142 | -247 | -11,747 |
| PPE Investments | -3,280 | -2,714 | -1,389 | -1,492 | -318 |
| Investing Cash Flow | $-36,224 | $-42,008 | $14,753 | $-1,739 | $-12,065 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -14 | -8 | -7 | -25 | -18 |
| Common Stock Issued | 129,847 | 129,583 | 289 | 65,748 | 65,065 |
| Financing Cash Flow | $129,833 | $129,575 | $282 | $65,723 | $65,047 |
| Exchange Rate Effect | 4 | 0 | 0 | N/A | N/A |
| Beginning Cash Position | 20,753 | 20,753 | 20,753 | 22,461 | 22,461 |
| End Cash Position | 55,723 | 67,213 | 14,094 | 20,753 | 26,045 |
| Net Cash Flow | $34,970 | $46,460 | $-6,659 | $-1,708 | $3,584 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58,643 | -41,107 | -21,694 | -65,692 | -49,398 |
| Capital Expenditure | -3,280 | -2,714 | -1,389 | -1,492 | -318 |
| Free Cash Flow | -61,923 | -43,821 | -23,083 | -67,184 | -49,716 |